This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Patel MS, Nemeria NS, Furey W, Jordan F. The pyruvate dehydrogenase complexes: structure-based function and regulation. J Biol Chem. 2014;289:16615-23.PatelMSNemeriaNSFureyWJordanFThe pyruvate dehydrogenase complexes: structure-based function and regulationJ Biol Chem201428916615–2310.1074/jbc.R114.563148405910524798336Search in Google Scholar
Maj MC, Cameron JM, Robinson BH. Pyruvate dehydrogenase phosphatase deficiency: orphan disease or an under-diagnosed condition? Mol Cell Endocrinol. 2006;249:1-9.MajMCCameronJMRobinsonBHPyruvate dehydrogenase phosphatase deficiency: orphan disease or an under-diagnosed condition?Mol Cell Endocrinol20062491–910.1016/j.mce.2006.02.00316574315Search in Google Scholar
Kara B, Genc HM, Uyur-Yalcin E, et al. Pyruvate dehydrogenase-E1alpha deficiency presenting as recurrent acute proximal muscle weakness of upper and lower extremities in an 8-year-old boy. Neuromuscul Disord. 2017;27:94-7.KaraBGencHMUyur-YalcinEet alPyruvate dehydrogenase-E1alpha deficiency presenting as recurrent acute proximal muscle weakness of upper and lower extremities in an 8-year-old boyNeuromuscul Disord20172794–710.1016/j.nmd.2016.11.00127894792Search in Google Scholar
Patel KP, O'Brien TW, Subramony SH, Shuster J, Stacpoole PW. The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients. Mol Genet Metab. 2012;106:385-94.PatelKPO'BrienTWSubramonySHShusterJStacpoolePWThe spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patientsMol Genet Metab2012106385–9410.1016/j.ymgme.2012.03.017400349222896851Search in Google Scholar
Stenlid MH, Ahlsson F, Forslund A, von Dobeln U, Gustafsson J. Energy substrate metabolism in pyruvate dehydrogenase complex deficiency. J Pediatr Endocrinol Metab. 2014;27:1059-64.StenlidMHAhlssonFForslundAvonDobeln UGustafssonJEnergy substrate metabolism in pyruvate dehydrogenase complex deficiencyJ Pediatr Endocrinol Metab2014271059–6410.1515/jpem-2013-042324914713Search in Google Scholar
DeBrosse SD, Okajima K, Zhang S, et al. Spectrum of neurological and survival outcomes in pyruvate dehydrogenase complex [PDC] deficiency: lack of correlation with genotype. Mol Genet Metab. 2012;107:394-402.DeBrosseSDOkajimaKZhangSet alSpectrum of neurological and survival outcomes in pyruvate dehydrogenase complex [PDC] deficiency: lack of correlation with genotypeMol Genet Metab2012107394–40210.1016/j.ymgme.2012.09.00123021068Search in Google Scholar
Imbard A, Boutron A, Vequaud C, et al. Molecular characterization of 82 patients with pyruvate dehydrogenase complex deficiency. Structural implications of novel amino acid substitutions in E1 protein. Mol Genet Metab. 2011;104:507-16.ImbardABoutronAVequaudCet alMolecular characterization of 82 patients with pyruvate dehydrogenase complex deficiency. Structural implications of novel amino acid substitutions in E1 proteinMol Genet Metab2011104507–1610.1016/j.ymgme.2011.08.00821914562Search in Google Scholar
Brown RM, Head RA, Boubriak II, Leonard JV, Thomas NH, Brown GK. Mutations in the gene for the E1beta subunit: a novel cause of pyruvate dehydrogenase deficiency. Hum Genet. 2004;115:123-7.BrownRMHeadRABoubriakIILeonardJVThomasNHBrownGKMutations in the gene for the E1beta subunit: a novel cause of pyruvate dehydrogenase deficiencyHum Genet2004115123–710.1007/s00439-004-1124-815138885Search in Google Scholar
Ciara E, Rokicki D, Halat P, et al. Difficulties in recognition of pyruvate dehydrogenase complex deficiency on the basis of clinical and biochemical features. The role of next-generation sequencing. Mol Genet Metab Rep. 2016;7:70-6.CiaraERokickiDHalatPet alDifficulties in recognition of pyruvate dehydrogenase complex deficiency on the basis of clinical and biochemical featuresThe role of next-generation sequencing. Mol Genet Metab Rep2016770–610.1016/j.ymgmr.2016.03.004484043127144126Search in Google Scholar
De Meirleir L. Defects of pyruvate metabolism and the Krebs cycle. J Child Neurol. 2002;17(Suppl 3):3S26-33.DeMeirleir LDefects of pyruvate metabolism and the Krebs cycleJ Child Neurol200217Suppl 33S26–3310.1177/088307380201703S01Search in Google Scholar
Kerr DS. Treatment of congenital lactic acidosis: a review. Int Pediatr. 1995;10:75–81.KerrDSTreatment of congenital lactic acidosis: a reviewInt Pediatr19951075–81Search in Google Scholar
Kossoff EH, Zupec-Kania BA, Amark PE, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2009;50:304-17.KossoffEHZupec-KaniaBAAmarkPEet alOptimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study GroupEpilepsia200950304–1710.1111/j.1528-1167.2008.01765.x18823325Search in Google Scholar
El-Gharbawy AH, Boney A, Young SP, Kishnani PS. Follow-up of a child with pyruvate dehydrogenase deficiency on a less restrictive ketogenic diet. Mol Genet Metab. 2011;102:214-5.El-GharbawyAHBoneyAYoungSPKishnaniPSFollow-up of a child with pyruvate dehydrogenase deficiency on a less restrictive ketogenic dietMol Genet Metab2011102214–510.1016/j.ymgme.2010.11.00121130013Search in Google Scholar
Stacpoole PW, Kerr DS, Barnes C, et al. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics. 2006;117:1519-31.StacpoolePWKerrDSBarnesCet alControlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in childrenPediatrics20061171519–3110.1542/peds.2005-122616651305Search in Google Scholar
